Analysis and presentation of the Scandinavian Candesartan Acute Stroke Trial (SCAST)
- Prosjektnummer
- 2012019
- Ansvarlig person
- Eivind Berge
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cardiovascular, Neurological, Stroke
- Forskningsaktivitet
- 6. Treatment Evaluation
Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months.
J Hypertens 2015 Jul;33(7):1487-91.
PMID: 26039534 - Inngår i doktorgradsavhandlingen
Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis.
Int J Stroke 2015 Apr;10(3):354-9. Epub 2014 des 3
PMID: 25472578
Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Int J Stroke 2015 Aug;10(6):830-5. Epub 2015 mar 22
PMID: 25808741 - Inngår i doktorgradsavhandlingen
Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke.
Stroke 2015 Mar;46(3):877-9. Epub 2015 feb 5
PMID: 25657183
Response to letter regarding article, "Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke".
Stroke 2015 Jan;46(1):e14. Epub 2014 des 9
PMID: 25492909
Blood pressure-lowering treatment in acute intracerebral haemorrhage.
J Hypertens 2015 May;33(5):931-2.
PMID: 25909696
Blood pressure and early neurological deterioration in acute ischemic stroke.
J Hypertens 2015 Oct;33(10):2020-1.
PMID: 26431189
Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial.
Stroke 2013 Jul;44(7):2022-4. Epub 2013 mai 9
PMID: 23660849 - Inngår i doktorgradsavhandlingen
Can angiotensin-converting enzyme inhibitors reduce the risk of pneumonia after stroke?
J Hypertens 2012 Nov;30(11):2088-9.
PMID: 23052047
Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
Stroke 2012 Aug;43(8):2108-14. Epub 2012 mai 24
PMID: 22627991
Blood pressure lowering treatment with candesartan in patients with acute hemorrhagic stroke
Stroke 2014;45:3440-2. DOI: 10.1161/STROKEAHA.114.006433
Very early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in SCAST
J Hypertens 2015 (submitted)
Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months
Oral presentation, European Stroke Conference, Nice, May 6-9, 2014. Cerebrovasc Dis 2014;37(Suppl. 1):1–2. DOI:10.1159/000362854
Effects of blood pressure lowering treatment with candesartan in acute stroke on vascular events during long-term follow-up
Oral presentation, European Stroke Conference, Nice, May 6-9, 2014. Cerebrovasc Dis 2014;37(Suppl. 1):1–2. DOI:10.1159/000362854
Effects of blood pressure lowering treatment with candesartan in acute stroke on vascular events during long-term follow-up
Oral presentation, Hypertension 2014, Joint Meeting of the ESH and ISH, Athens, June 13-16, 2014. J Hypertens 2014;32,e-Suppl. 1
Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months
J Hypertens (accepted)
Effects of candesartan in acute stroke on vascular events during long-term follow-up
Int J Stroke (accepted)
Maximum systolic blood pressure and blood pressure variability in acute stroke: Are they important for prognosis? (Abstract)
J Hypertens 2013;35:e-Suppl. A
Effects of candesartan on blood pressure variability in acute stroke: Is it important for prognosis? (Abstract)
Cerebrovasc Dis 2013;35 (Suppl. 3). Available at: www.karger.com/CED_2013_035_S3
Effects of candesartan in acute stroke on level of care at 6 months (Abstract)
Cerebrovasc Dis 2013;35 (Suppl. 3): Available at: www.karger.com/CED_2013_035_S3
Effects of candesartan on blood pressure variability in acute stroke: Is it important for prognosis?
Lancet Neurology (In preparation)
Effects of blood pressure lowering in different subtypes of acute ischaemic stroke
International Journal of Stroke (In preparation)
Effects of candesartan in patients with acute ischemic stroke and carotid artery stenosis
Journal of Neurology, Neurosurgery and Psychiatry 2013 (Submitted)
Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months
Cerebrovascular Diseases 2013 (In preparation)
Effect of blood pressure lowering treatment in acute ischaemic stroke depends on stroke subtype and severity
Hypertension Sydney 2012, Sydney, September 30-October 4, 2012. J Hypertens 2012;30:e-Suppl. B
Effects of blood pressure lowering treatment in acute stroke on quality of life at 6 months
Hypertension Sydney 2012, Sydney, September 30-October 4, 2012. J Hypertens 2012;30:e-Suppl. B
Effects of candesartan in acute stroke on cognitive function at 6 months
Hypertension Sydney 2012, Sydney, September 30-October 4, 2012. J Hypertens 2012;30:e-Suppl. B
Effects of blood pressure lowering in different subtypes of acute ischaemic stroke
European Stroke Conference, Lisbon, May 22-25, 2012. Cerebrovasc Dis 2012;33(Suppl.2):1-2. DOI:10.1159/000339538
Effect of candesartan in acute stroke on cognitive function and quality of life at 6 months
European Stroke Conference, Lisbon, May 22-25, 2012. Cerebrovasc Dis 2012;33(Suppl.2):1-2. DOI:10.1159/000339538
Large reduction in SBP in acute stroke is associated with an increased risk of early adverse events
European Society of Hypertension, London April 26-29, 2012. J Hypertens 2012;30(e-Suppl. A):e109
Effects of candesartan in acute stroke on cognitive function and quality of life
Submitted to Stroke
Effects of blood pressure lowering treatment in acute stroke
- Disputert:
- oktober 2015
- Hovedveileder:
- Eivind Berge
- Eivind Berge Prosjektleder
- Jannicke Igland Prosjektdeltaker
- Gudrun Boysen Prosjektdeltaker
- Andreas Terént Prosjektdeltaker
- Gordon M. Murray Prosjektdeltaker
- Philip M. Bath Prosjektdeltaker
- Torgeir Bruun Wyller Medveileder
- Else Charlotte Sandset Medveileder
- Astrid Hornslien Doktorgradsstipendiat
- Gordon D. Murray Prosjektdeltaker
- Astrid Gjerdrum Hornslien Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport